Given that CXCL8 is significantly associated with the prognosis of patients and plays an important role in predicting tumor recurrence and occult lymph node metastasis, it is expected to become a key molecular target to guide the formulation of individualized drug treatment strategies for high-risk patients with OSCC (70). The gene discussed is CXCL8; the disease is neoplasm.